Alimera Sciences , Nasdaq: ALIM
Developing an injectable implant to treat eye diseases.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
ALIM
Developing an injectable implant to treat eye diseases.
| IPO Data | |
|---|---|
| IPO File Date | 10/30/2009 |
| Offer Price | $11.00 |
| Price Range $15.00 - $17.00 | |
| Offer Shares (mm) | 6.6 |
| Deal Size ($mm) | $72 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 04/21/2010 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $72 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Alpharetta, GA, United States |
| Founded | 2003 |
| Employees at IPO | 21 |
| Website www.alimerasciences.com | |
IPO News for Alimera Sciences
Alimera Sciences (ALIM) Performance
